Analysis, Health and Fitness

Patient Advocacy Group Releases Comparative Analysis of DEA Marijuana Scheduling Decision

Concludes DEA ignored critical data supporting safety and efficacy for therapeutic use

Most read stories this week

Take a Survey

ARCHIVES